References
- Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD. Best practice no 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 2004;57:897-902
- Allison KH, Eby PR, Kohr J, DeMartini WB, Lehman CD. Atypical ductal hyperplasia on vacuum-assisted breast biopsy: suspicion for ductal carcinoma in situ can stratify patients at high risk for upgrade. Hum Pathol 2011;42:41-50
- Acheson MB, Patton RG, Howisey RL, Lane RF, Morgan A. Histologic correlation of image-guided core biopsy with excisional biopsy of nonpalpable breast lesions. Arch Surg 1997;132:815-818; discussion 819-821
- Liberman L, Cohen MA, Dershaw DD, Abramson AF, Hann LE, Rosen PP. Atypical ductal hyperplasia diagnosed at stereotaxic core biopsy of breast lesions: an indication for surgical biopsy. AJR Am J Roentgenol 1995;164:1111-1113
- Lin PH, Clyde JC, Bates DM, Garcia JM, Matsumoto GH, Girvin GW. Accuracy of stereotactic core-needle breast biopsy in atypical ductal hyperplasia. Am J Surg 1998;175:380-382
- Brem RF. Management of breast atypical ductal hyperplasia: now and the future. Radiology 2020;294:87-88
- Forester ND, Lowes S, Mitchell E, Twiddy M. High risk (B3) breast lesions: what is the incidence of malignancy for individual lesion subtypes? A systematic review and meta-analysis. Eur J Surg Oncol 2019;45:519-527
- Sharma N, Wilkinson LS, Pinder SE. The B3 conundrum-the radiologists' perspective. Br J Radiol 2017;90:20160595
- Wagoner MJ, Laronga C, Acs G. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision. Am J Clin Pathol 2009;131:112-121
- Degnim AC, King TA. Surgical management of high-risk breast lesions. Surg Clin North Am 2013;93:329-340
- Ely KA, Carter BA, Jensen RA, Simpson JF, Page DL. Core biopsy of the breast with atypical ductal hyperplasia: a probabilistic approach to reporting. Am J Surg Pathol 2001;25:1017-1021
- Forgeard C, Benchaib M, Guerin N, Thiesse P, Mignotte H, Faure C, et al. Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients. Am J Surg 2008;196:339-345
- Kim J, Han W, Go EY, Moon HG, Ahn SK, Shin HC, et al. Validation of a scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia using an ultrasound-guided core needle biopsy. J Breast Cancer 2012;15:407-411
- Ko E, Han W, Lee JW, Cho J, Kim EK, Jung SY, et al. Scoring system for predicting malignancy in patients diagnosed with atypical ductal hyperplasia at ultrasound-guided core needle biopsy. Breast Cancer Res Treat 2008;112:189-195
- Sneige N, Lim SC, Whitman GJ, Krishnamurthy S, Sahin AA, Smith TL, et al. Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. Am J Clin Pathol 2003;119:248-253
- Schiaffino S, Calabrese M, Melani EF, Trimboli RM, Cozzi A, Carbonaro LA, et al. Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions. Radiology 2020;294:76-86
- Schiaffino S, Massone E, Gristina L, Fregatti P, Rescinito G, Villa A, et al. Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia. Br J Radiol 2018;91:20180003
- Rageth CJ, O'Flynn EA, Comstock C, Kurtz C, Kubik R, Madjar H, et al. First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2016;159:203-213
- Nguyen CV, Albarracin CT, Whitman GJ, Lopez A, Sneige N. Atypical ductal hyperplasia in directional vacuum- assisted biopsy of breast microcalcifications: considerations for surgical excision. Ann Surg Oncol 2011;18:752-761
- Pena A, Shah SS, Fazzio RT, Hoskin TL, Brahmbhatt RD, Hieken TJ, et al. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia. Breast Cancer Res Treat 2017;164:295-304
- Yeh IT, Dimitrov D, Otto P, Miller AR, Kahlenberg MS, Cruz A. Pathologic review of atypical hyperplasia identified by image-guided breast needle core biopsy. Correlation with excision specimen. Arch Pathol Lab Med 2003;127:49-54
- Degnim AC, Visscher DW, Berman HK, Frost MH, Sellers TA, Vierkant RA, et al. Stratification of breast cancer risk in women with atypia: a Mayo cohort study. J Clin Oncol 2007;25:2671-2677
- Renshaw AA, Cartagena N, Schenkman RH, Derhagopian RP, Gould EW. Atypical ductal hyperplasia in breast core needle biopsies. Correlation of size of the lesion, complete removal of the lesion, and the incidence of carcinoma in follow-up biopsies. Am J Clin Pathol 2001;116:92-96
- Krishnamurthy S, Bevers T, Kuerer H, Yang WT. Multidisciplinary considerations in the management of high-risk breast lesions. AJR Am J Roentgenol 2012;198:W132-W140
- Sickles EA, D'Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES. ACR BI-RADSⓇ atlas: mammography. In American College of Radiology, ed. ACR BI-RADSⓇ atlas: breast imaging reporting and data system, 5th ed. Reston, VA: American College of Radiology 2013:5-175
- Cao C, Louie BE, Melfi F, Veronesi G, Razzak R, Romano G, et al. Impact of pulmonary function on pulmonary complications after robotic-assisted thoracoscopic lobectomy. Eur J Cardiothorac Surg 2019;57:338-342
- Deshaies I, Provencher L, Jacob S, Cote G, Robert J, Desbiens C, et al. Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy. Breast 2011;20:50-55
- Jung I, Kim MJ, Moon HJ, Yoon JH, Kim EK. Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience. Ultrasonography 2018;37:55-62
- Rageth CJ, Rubenov R, Bronz C, Dietrich D, Tausch C, Rodewald AK, et al. Atypical ductal hyperplasia and the risk of underestimation: tissue sampling method, multifocality, and associated calcification significantly influence the diagnostic upgrade rate based on subsequent surgical specimens. Breast Cancer 2019;26:452-458
- Chae BJ, Lee A, Song BJ, Jung SS. Predictive factors for breast cancer in patients diagnosed atypical ductal hyperplasia at core needle biopsy. World J Surg Oncol 2009;7:77
- Mesurolle B, Perez JC, Azzumea F, Lemercier E, Xie X, Aldis A, et al. Atypical ductal hyperplasia diagnosed at sonographically guided core needle biopsy: frequency, final surgical outcome, and factors associated with underestimation. AJR Am J Roentgenol 2014;202:1389-1394
- Rageth CJ, O'Flynn EAM, Pinker K, Kubik-Huch RA, Mundinger A, Decker T, et al. Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 2019;174:279-296